Intestinal inflammation is a hallmark of the inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn’s disease. These chronic autoimmune GI illnesses affect upwards of 3 million children and adults in the United States. Many of the symptoms in patients with IBD overlap with those observed in patients with irritable bowel syndrome (IBS), a discrete Read More
Join Genomind Medical Science Liaisons, Dr. Russell Amato, PhD and Dr. Seema Patel, PharmD, as they present on the management of attention-deficit hyperactivity disorder (ADHD). They discuss various treatment options and associated evidence, as well as highlight pharmacogenetic considerations in the management of this challenging clinical presentation.
The LEUKO EZ VUE® is an immunochromatographic test for the qualitative detection of elevated levels of fecal lactoferrin, a marker for fecal leukocytes and an indicator of intestinal inflammation. The LEUKO EZ VUE® test detects lactoferrin in liquid, semi-liquid, and solid fecal specimens. • Does not require intact cells: Unaffected by lysed and degraded leukocytes. • Longer specimen storage: Read More
Patented upflow technology offers a clean background and clear signal. • EIA device specifically developed for fecal sample. • Wash step removes unbound material away from test line for increased clarity. • Antibody-peroxidase conjugates increase signal sensitivity to particle detection. • Special porous pads and membranes help avoid clogging
1 in 54 children are diagnosed with Autism Spectrum Disorder. Often a child diagnosed with it will be prescribed a complex cocktail of medications. The challenge is determining the best treatment plan, while taking into account drug interactions and side effects. Thanks to advances in testing, there’s a way to take into account a patient’s Read More